Delivery Order SPE2DB24D9113-SPE2DB25FEPYH

Award Date 4/2/25
Potential Completion Date 4/23/25
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,063.78 firm fixed-price contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a period of performance through February 28, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,127.56 firm fixed-price contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product, with a period of performance through February 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $11,422.56 and has a firm fixed-price pricing type. It is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period ending on July 19, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,855.66 contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $17,133.84, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML. The contract is a firm fixed-price delivery order with a completion date of May 24, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,283.46 firm fixed-price contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of July 24, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,928.66, is for the delivery of EXPAREL, a 266 mg/20 ml vial pharmaceutical product, with a performance period through March 9, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.70 contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
This is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,321.65 firm fixed-price contract is for the delivery of EXPAREL, a 266 mg/20 ml injectable pharmaceutical product, with a completion date of June 21, 2023. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a $24,872.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML and has a completion date of May 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award...
  • SPE2DB24D9113
    Indefinite Delivery Contract
  • SPE2DB24D9113-SPE2DB25FEPYH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,028.88 firm fixed-price contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through April 23, 2025.

DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This specific delivery order is not associated with any set-aside designation.

Generated 7/2/25, 10:24 PM